Here's the pattern women report most often. You go in describing low mood, irritability, anxiety, a general sense of not coping. You come out with an antidepressant prescription, no discussion of whether this might be menopausal, and a distinct feeling of having been filed.

Sometimes an antidepressant is exactly right. But the sequence — mood mentioned, antidepressant offered, nothing else considered — is common enough to be worth preparing for.

Why it happens

Not usually indifference.

Mood symptoms are non-specific. Fatigue, poor sleep, low concentration and irritability appear on the depression criteria and are also standard features of the menopausal transition. Distinguishing them requires time and specific questions.

There's also a documented tendency for women's symptoms to be attributed to psychological causes more readily than men's, which is worth knowing not as grievance but as something to actively counter.

And there's an availability problem. Antidepressants are a fast, familiar action. Working out whether this is perimenopausal mood change requires a longer conversation about cycles and stage.

What the guidelines actually say

This is your strongest tool, and most women don't know it exists.

NICE guidance states that clinicians should consider HRT to alleviate low mood arising as a result of menopause, and should consider CBT to alleviate low mood or anxiety arising as a result of menopause.

It also states there is no clear evidence that SSRIs or SNRIs ease low mood in menopausal women who have not been diagnosed with depression.

Read that last one carefully. It means if you have menopause-related low mood and haven't been assessed as having depression, an antidepressant isn't the guideline-supported first move.

Separately, expert guidance developed jointly by menopause and women's mental health specialists concluded that for a diagnosed major depressive episode, antidepressants remain first-line — and that estrogen therapy has evidence for depressive symptoms in perimenopausal women specifically.

So both things are true, and which applies depends on an assessment that has to actually happen.

Be the first to know when we launch.

We'll only email you about the launch. See our privacy policy.

How to raise it

Lead with the menopause frame. "I'm having mood changes and I think they're connected to perimenopause" sets a different course than "I've been feeling low." The first invites investigation of a cause. The second invites a prescription.

Give the timeline and the correlation. "It started around the same time my cycles became irregular, about a year ago" or "it's worst in the week before I bleed and lifts once I do." Cyclical patterning is meaningful evidence and it's the sort of thing clinicians rarely ask about but readily act on.

Describe function, not feeling. "I've stopped going out. I'm short with my children in a way I never was. I haven't been able to concentrate at work for months." Concrete impact carries more weight than emotional description, unfair as that is.

Separate the strands. "I'm not sad exactly — I'm irritable, and flat, and everything feels like effort." Perimenopausal mood change often doesn't present as sadness, and saying so prevents a mismatch between what you're experiencing and what gets recorded.

Say what you want considered. "I'd like to discuss whether HRT might help, and whether CBT is available, as well as antidepressants." That single sentence puts all three options on the table.

If you're offered an antidepressant

Not a fight. Two useful questions.

"Are you treating this as depression, or as a menopausal mood symptom?" This is a fair question and it usually prompts the assessment that should have happened.

"Would HRT be reasonable to consider, given the timing with my cycle changes?" Framed as a question rather than a demand, and it references the guideline position without needing to cite it.

If the answer is a proper assessment concluding you have depression, antidepressants are evidence-based and worth taking seriously. Reluctance based on principle rather than clinical reasoning isn't serving you. What you're pushing back against is the prescription without the assessment, not the medication itself.

Where the line is

If you have thoughts of ending your life, or of not wanting to be here, say so directly and today. To a doctor, a crisis line, or someone in your house.

Don't wait for the right appointment or the right framing. That symptom needs a response now, and there is help for it.

Sources

- National Institute for Health and Care Excellence. Menopause: identification and management (NG23), recommendations on mood. Updated 2024. - Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018;25(10):1069–1085. - Bromberger JT, Kravitz HM, Chang YF, et al. Major depression during and after the menopausal transition: SWAN. Psychological Medicine. 2011;41(9):1879–1888. - Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry. 2006;63(4):375–382.